Purav Patel insider trades
Open-market stock purchases and sales by Purav Patel, Director at Reviva Pharmaceuticals Holdings, Inc, from SEC Form 4 filings since Apr 14, 2021.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -92%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Dec 18, 2025 | RVPH Reviva Pharmaceuticals Holdings, Inc | Bought (not open market) | — |
Companies traded
- RVPH Reviva Pharmaceuticals Holdings, Inc: 1 buy, last Dec 18, 2025